Nearly 9 out of 10 at risk women mistrust breast cancer prevention drugs

Nearly 90 per cent of women who are offered a preventative treatment against breast cancer turn down the medication.

That is according to a study funded by Cancer Research UK in Britain, which found that these women mistrust the drugs, fear side effects and, in some cases, believe it is their fate to get the disease.

It has been the policy to recommend tamoxifen to women with a high risk of breast cancer due to a family history of the disease since 2013.

Despite cutting the chances of developing breast cancer by one-third, many women decide that the menopause-like symptoms are not worth it.

Interestingly, it is those who have children of their own who were most likely to take the drug.
One 38-year-old mother of two told the Independent: “I’m not necessarily going to get breast cancer, but if it can prevent it, I would be willing to take it, definitely.

“Obviously I’ve got young children to think about now. I would be happy to start taking it, but yes, I do look at the side effects.”

In comparison, a 59-year-old woman spoke of her decision not to go on the tamoxifen tablets, saying that with the responsibility of looking after her parents and children, she simply couldn’t handle the side effects in the short term.

Some of the respondents to the survey said that taking such medications went against their own personal attitude towards drugs, while others had seen family and friends battle the side effects and still end up with cancer.

One 47-year-old patient explained that since her mother had died from breast cancer she had always expected to have her own battle with the disease at some point.

She told the news provider: “It’s kind of written in the stars – that it’s my fate. So, what then would have been the point of any breast cancer prevention?”ADNFCR-2094-ID-801846390-ADNFCR